About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT00139022

Home Diagnosis and Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea (OSA) is a common and underrecognised condition. The diagnosis of OSA is typically made after an in-lab polysomnography (PSG) which requires an overnight stay in a sleep labora...

Lead sponsor: University of Saskatchewan•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University of Saskatchewan

We will randomise patients suspected to have OSA to either home evaluation and treatment (using a portable monitor and auto-CPAP) or in-lab evaluation with a PSG and manually-titrated CPAP. We will obtain sleep, sleepiness and quality of life questionnaires, vigilance testing and blood pressure at baseline and after 1, 2, 4 and 12 weeks of therapy. We will also assess and compare compliance with CPAP therapy in each arm of the study.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•adult ( age \> 18)
•suspected OSA
•no coexisting heart or lung disease
•not in a safety-sensitive occupation

Exclusion Criteria

•\-

Related studies

Comparative Study of CPAP Predictive Equations and In-laboratory Manual Titration in Thai Patients With Obstructive Sleep Apnea

NCT07376343 · OSA - Obstructive Sleep Apnea

Stroke and CPAP Outcome Study 3 Randomized Controlled Trial

NCT06722755 · Stroke Patients, CPAP, and more

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

NCT06430957 · Obstructive Sleep Apnea Risk Management, Postoperative Complications, and more

Digital-supported Orofacial Myofunctional Therapy in OSA

NCT07292922 · Obstructive Sleep Apnea (OSA)

RECRUITINGPhase 3

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

NCT07225686 · Obesity, Obstructive Sleep Apnea

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 10, 2007Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment50

Start dateNov 2004

Last updatedOct 10, 2007

Condition

Obstructive Sleep Apnea

Locations shown

Sleep Disorders Center, Royal Univerisity Hospital

Saskatoon, Saskatchewan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 10, 2007Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions